Diagnosis and Management of Heparin-Induced Thrombocytopenia

被引:36
作者
Lee, Grace M. [1 ]
Arepally, Gowthami M. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
Platelet factor 4; PF4; Heparin; PF4/H complexes; HIT; MOLECULAR-WEIGHT HEPARIN; INTERNATIONAL NORMALIZED RATIO; CARDIOPULMONARY BYPASS-SURGERY; PARTICLE GEL IMMUNOASSAY; SINGLE-CENTER EXPERIENCE; INDUCED SKIN-LESIONS; INTENSIVE-CARE-UNIT; PLATELET FACTOR-IV; FC-GAMMA-RIIA; CARDIAC-SURGERY;
D O I
10.1016/j.hoc.2013.02.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder caused by antibodies to platelet factor 4/heparin (PF4/H) complexes. It presents with declining platelet counts 5 to 14 days after heparin administration and results in a predisposition to arterial and venous thrombosis. Establishing the diagnosis of HIT can be extremely challenging. It is essential to conduct a thorough clinical evaluation in addition to laboratory testing to confirm the presence of PF4/H antibodies. Multiple clinical algorithms have been developed to aid the clinician in predicting the likelihood of HIT. Once HIT is recognized, an alternative anticoagulant should be initiated to prevent further complications.
引用
收藏
页码:541 / +
页数:25
相关论文
共 130 条
[1]   Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia [J].
Alberio, L ;
Kimmerle, S ;
Baumann, A ;
Taleghani, BRM ;
Biasiutti, FD ;
Lämmle, B .
AMERICAN JOURNAL OF MEDICINE, 2003, 114 (07) :528-536
[2]   Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay [J].
Althaus, Karina ;
Strobel, Ulrike ;
Warkentin, Theodore E. ;
Greinacher, Andreas .
THROMBOSIS RESEARCH, 2011, 128 (03) :256-260
[3]  
AMIRAL J, 1992, THROMB HAEMOSTASIS, V68, P95
[4]  
Amiral J, 1996, AM J HEMATOL, V52, P90, DOI 10.1002/(SICI)1096-8652(199606)52:2<90::AID-AJH4>3.3.CO
[5]  
2-5
[6]  
[Anonymous], 2012, MED LETT DRUGS THER, V54, P43
[7]  
Arepally G, 1995, AM J CLIN PATHOL, V104, P648
[8]   Heparin-induced thrombocytopenia [J].
Arepally, Gowthami M. ;
Ortel, Thomas L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (08) :809-817
[9]   Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarin [J].
Arpino, PA ;
Demirjian, Z ;
Van Cott, EM .
PHARMACOTHERAPY, 2005, 25 (02) :157-164
[10]   HEPARIN-INDUCED IMMUNE THROMBOCYTOPENIA [J].
BABCOCK, RB ;
DUMPER, W ;
SCHARFMAN, WB .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (05) :237-241